Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov registry

American Heart Journal

Volumn 168, Issue 2, 2014, Pages

  Bernardez Pereira, Sabrina ^a,b   Lopes, Renato D ^c,d   Carrion, Maria Julia Machline ^a   Santucci, Eliana Vieira ^a   Soares, Rafael Marques ^a   De Oliveira Abreu, Matheus ^a   Laranjeira, Ligia Nasi ^a   Ikeoka, Dimas T ^a   Zazula, Ana Denise ^a   Moreira, Frederico Rafael ^a   Cavalcanti, Alexandre Biasi ^a   Mesquita, Evandro Tinoco ^b   Peterson, Eric D ^c   Califf, Robert M ^e   Berwanger, Otavio ^a  

^a Department of Radiology and Nuclear Medicine   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Brazilian Clinical Research Institute   (Brazil)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); CONFIDENCE INTERVAL; DATA BASE; DIET; EARLY TERMINATION OF CLINICAL TRIAL; FUNDING; HUMAN; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL;

ADULT; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; EARLY TERMINATION OF CLINICAL TRIALS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATIONAL LIBRARY OF MEDICINE (U.S.); PATIENT SELECTION; PREVALENCE; REGISTRIES; SELECTION BIAS; UNITED STATES;

EID: 84905121663     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.04.013     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention Compressed mortality file: underlying cause of death, 1979 to 2005 http://wonder.cdc.gov/mortSQL.html [Accessed February 28, 2014]
2. A. Avenell, A.M. Grant, and M. McGee et al. The effects of an open design on trial participant recruitment, compliance and retention - a randomized controlled trial comparison with a blinded, placebo-controlled design Clin Trials 1 2004 490 498
3. R.M. Califf, D.A. Zarin, and J.M. Kramer et al. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010 JAMA 307 2012 1838 1847
4. D.A. Zarin, T. Tse, and R.J. Williams et al. The ClinicalTrials.gov results database - update and key issues N Engl J Med 364 2011 852 860
5. D.A. Zarin, T. Tse, and N.C. Ide Trial registration at ClinicalTrials.gov between May and October 2005 N Engl J Med 353 2005 2779 2787
6. D.A. Zarin, N.C. Ide, and T. Tse et al. Issues in the registration of clinical trials JAMA 297 2007 2112 2120
7. ClinicalTrials.gov protocol Data Element Definitions (DRAFT) http://prsinfo.clinicaltrials.gov/definitions.html 2013 [Accessed April 4, 2013]
8. National Center for Biotechnology Information MeSH terms: cardiovascular diseases http://www.ncbi.nlm.nih.gov/mesh?Db=mesh&term= Cardiovascular+Diseases 2013 [Accessed April 4, 2013]
9. R Core Team R: a language and environment for statistical computing http://www.R-project.org/ 2013 [Accessed April 4, 2013]
10. AACT Database Clinical Trials Transformation Initiative Web site http://www.ctti-clinicaltrials.org/what-we-do/analysis-dissemination/ state-clinical-trials/aact-database 2013 [Accessed April 4, 2013]
11. P.D. Allison Logistic regression using the SAS system: theory and application 2001 SAS Institute Cary, NC
12. D.W. Hosmer, and S. Lemeshow Applied logistic regression 2nd ed. 2000 John Wiley & Sons New York
13. A.M. McDonald, R.C. Knight, and M.K. Campbell et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies Trials 7 2006 9
14. T. Reynolds Clinical trials: can technology solve the problem of low recruitment? BMJ 342 2011 d3662
15. National Institutes of Health Our economy http://www.nih.gov/about/ impact/economy.htm 2013 [Accessed August 15, 2013]
16. H.R. Black, W.J. Elliott, and G. Grandits et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial JAMA 289 2003 2073 2082
17. D.R. Kitterman, S.K. Cheng, and D.M. Dilts et al. The prevalence and economic impact of low-enrolling clinical studies at an academic medical center Acad Med 86 2011 1360 1366
18. S.S. Martin, F.S. Ou, and L.K. Newby et al. Patient and trial specific barriers to participation in cardiovascular randomized clinical trials J Am Coll Cardiol 61 7 2013 762 769
19. S.J. Bowman, and G.J. Macfarlane Arthritis Research Campaign Data Monitoring Committee. Successful patient recruitment in investigator-led clinical trials Rheumatology (Oxford) 46 7 2007 1207 1208
20. D.L. DeMets, and R.M. Califf Lessons learned from recent cardiovascular clinical trials: part II Circulation 106 7 2002 880 886
21. B. Als-Nielsen, W. Chen, and C. Gluud et al. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290 7 2003 921 928
22. W.J. Jack, U. Chetty, and A. Rodger Recruitment to a prospective breast conservation trial: why are so few patients randomised? BMJ 301 1990 83 85
23. H.A. Llewellyn-Thomas, M.J. McGreal, and E.C. Thiel et al. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation Soc Sci Med 32 1991 35 42
24. A. Yeomans-Kinney, S.W. Vernon, and R.F. Frankowski et al. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment Cancer 76 1995 46 56